809 related articles for article (PubMed ID: 24182989)
1. Anti-fibrotic effect of thymoquinone on hepatic stellate cells.
Ghazwani M; Zhang Y; Gao X; Fan J; Li J; Li S
Phytomedicine; 2014 Feb; 21(3):254-60. PubMed ID: 24182989
[TBL] [Abstract][Full Text] [Related]
2. Thymoquinone attenuates liver fibrosis via PI3K and TLR4 signaling pathways in activated hepatic stellate cells.
Bai T; Lian LH; Wu YL; Wan Y; Nan JX
Int Immunopharmacol; 2013 Feb; 15(2):275-81. PubMed ID: 23318601
[TBL] [Abstract][Full Text] [Related]
3. Thymoquinone alleviates thioacetamide-induced hepatic fibrosis and inflammation by activating LKB1-AMPK signaling pathway in mice.
Bai T; Yang Y; Wu YL; Jiang S; Lee JJ; Lian LH; Nan JX
Int Immunopharmacol; 2014 Apr; 19(2):351-7. PubMed ID: 24560906
[TBL] [Abstract][Full Text] [Related]
4. Resveratrol Regulates Activated Hepatic Stellate Cells by Modulating NF-κB and the PI3K/Akt Signaling Pathway.
Zhang DQ; Sun P; Jin Q; Li X; Zhang Y; Zhang YJ; Wu YL; Nan JX; Lian LH
J Food Sci; 2016 Jan; 81(1):H240-5. PubMed ID: 26613251
[TBL] [Abstract][Full Text] [Related]
5. Selective inactivation of NF-kappaB in the liver using NF-kappaB decoy suppresses CCl4-induced liver injury and fibrosis.
Son G; Iimuro Y; Seki E; Hirano T; Kaneda Y; Fujimoto J
Am J Physiol Gastrointest Liver Physiol; 2007 Sep; 293(3):G631-9. PubMed ID: 17640975
[TBL] [Abstract][Full Text] [Related]
6. Upregulation of SIRT1-AMPK by thymoquinone in hepatic stellate cells ameliorates liver injury.
Yang Y; Bai T; Yao YL; Zhang DQ; Wu YL; Lian LH; Nan JX
Toxicol Lett; 2016 Nov; 262():80-91. PubMed ID: 27688165
[TBL] [Abstract][Full Text] [Related]
7. Phillygenin inhibits LPS-induced activation and inflammation of LX2 cells by TLR4/MyD88/NF-κB signaling pathway.
Hu N; Wang C; Dai X; Zhou M; Gong L; Yu L; Peng C; Li Y
J Ethnopharmacol; 2020 Feb; 248():112361. PubMed ID: 31683033
[TBL] [Abstract][Full Text] [Related]
8. Glycyrrhizic acid inhibits apoptosis and fibrosis in carbon-tetrachloride-induced rat liver injury.
Liang B; Guo XL; Jin J; Ma YC; Feng ZQ
World J Gastroenterol; 2015 May; 21(17):5271-80. PubMed ID: 25954100
[TBL] [Abstract][Full Text] [Related]
9. Plumbagin ameliorates liver fibrosis via a ROS-mediated NF-кB signaling pathway in vitro and in vivo.
Chen Y; Zhao C; Liu X; Wu G; Zhong J; Zhao T; Li J; Lin Y; Zhou Y; Wei Y
Biomed Pharmacother; 2019 Aug; 116():108923. PubMed ID: 31154269
[TBL] [Abstract][Full Text] [Related]
10. Hydroxysafflor yellow A attenuates carbon tetrachloride-induced hepatic fibrosis in rats by inhibiting ERK5 signaling.
Zhang YB; Dong HY; Zhao XM; Fan L; Zou Y; Zhang C; Li G; Liu JC; Niu YC
Am J Chin Med; 2012; 40(3):481-94. PubMed ID: 22745065
[TBL] [Abstract][Full Text] [Related]
11. Liuweiwuling tablets attenuate BDL-induced hepatic fibrosis via modulation of TGF-β/Smad and NF-κB signaling pathways.
Liu H; Dong F; Li G; Niu M; Zhang C; Han Y; He L; Yin P; Wang B; Sang X; Li R; Wang J; Bai Z; Xiao X
J Ethnopharmacol; 2018 Jan; 210():232-241. PubMed ID: 28864168
[TBL] [Abstract][Full Text] [Related]
12. A comparison of the effects of thymoquinone, silymarin and N-acetylcysteine in an experimental hepatotoxicity.
Demiroren K; Basunlu MT; Erten R; Cokluk E
Biomed Pharmacother; 2018 Oct; 106():1705-1712. PubMed ID: 30119245
[TBL] [Abstract][Full Text] [Related]
13. Antioxidant properties of red raspberry extract alleviate hepatic fibrosis via inducing apoptosis and transdifferentiation of activated hepatic stellate cells.
Wu TH; Wang PW; Lin TY; Yang PM; Li WT; Yeh CT; Pan TL
Biomed Pharmacother; 2021 Dec; 144():112284. PubMed ID: 34626932
[TBL] [Abstract][Full Text] [Related]
14. Plumbagin protects liver against fulminant hepatic failure and chronic liver fibrosis via inhibiting inflammation and collagen production.
Wang H; Zhang H; Zhang Y; Wang D; Cheng X; Yang F; Zhang Q; Xue Z; Li Y; Zhang L; Yang L; Miao G; Li D; Guan Z; Da Y; Yao Z; Gao F; Qiao L; Kong L; Zhang R
Oncotarget; 2016 Dec; 7(50):82864-82875. PubMed ID: 27756878
[TBL] [Abstract][Full Text] [Related]
15. Protective effect of ethyl acetate fraction of Drynaria quercifolia against CCl
Anuja GI; Shine VJ; Latha PG; Suja SR
J Ethnopharmacol; 2018 Apr; 216():79-88. PubMed ID: 29174446
[TBL] [Abstract][Full Text] [Related]
16. Diethylcarbamazine attenuates the expression of pro-fibrogenic markers and hepatic stellate cells activation in carbon tetrachloride-induced liver fibrosis.
França MER; Rocha SWS; Oliveira WH; Santos LA; de Oliveira AGV; Barbosa KPS; Nunes AKS; Rodrigues GB; Lós DB; Peixoto CA
Inflammopharmacology; 2018 Apr; 26(2):599-609. PubMed ID: 28409388
[TBL] [Abstract][Full Text] [Related]
17. Smad2 increases the apoptosis of activated human hepatic stellate cells induced by TRAIL.
Xu F; Zhou D; Meng X; Wang X; Liu C; Huang C; Li J; Zhang L
Int Immunopharmacol; 2016 Mar; 32():76-86. PubMed ID: 26802603
[TBL] [Abstract][Full Text] [Related]
18. Thymoquinone attenuates proinflammatory responses in lipopolysaccharide-activated mast cells by modulating NF-kappaB nuclear transactivation.
El Gazzar MA; El Mezayen R; Nicolls MR; Dreskin SC
Biochim Biophys Acta; 2007 Apr; 1770(4):556-64. PubMed ID: 17292554
[TBL] [Abstract][Full Text] [Related]
19. PBI-4050 Reduces Stellate Cell Activation and Liver Fibrosis through Modulation of Intracellular ATP Levels and the Liver Kinase B1/AMP-Activated Protein Kinase/Mammalian Target of Rapamycin Pathway.
Grouix B; Sarra-Bournet F; Leduc M; Simard JC; Hince K; Geerts L; Blais A; Gervais L; Laverdure A; Felton A; Richard J; Ouboudinar J; Gagnon W; Leblond FA; Laurin P; Gagnon L
J Pharmacol Exp Ther; 2018 Oct; 367(1):71-81. PubMed ID: 30093459
[TBL] [Abstract][Full Text] [Related]
20. Study on the Antifibrotic Effects of Recombinant Shark Hepatical Stimulator Analogue (r-sHSA) in Vitro and in Vivo.
Wang Y; Zhang X; Yang Y; Yang X; Ye B
Mar Drugs; 2015 Aug; 13(8):5201-18. PubMed ID: 26295240
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
